![Page 1: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/1.jpg)
Silicon Nanotechnology and Hemofiltration
Membranes
l l 1
September 30, 2011
William H. Fissell, MD
![Page 2: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/2.jpg)
The Problem (1)
0
100,000
200,000
300,000
400,000
500,000
600,000
1975 1980 1985 1990 1995 2000 2005 2010
0
20,000
40,000
60,000
80,000
100,000
120,000
Transplant
Prevalence
Incidence
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
1990 1995 2000 2005 2010
Medicare ESRD
Medicare Total
l l 2
0-19
0-19
0-19
0-19
20-29
20-29
20-29
20-29
30-39
30-39
30-39
30-39
40-49
40-49
40-49
40-49
50-59
50-59
50-59
50-59
60-64
60-64
60-64
60-64
65-69
65-69
65-69
65-69
70-79
70-79
70-79
70-79
80
80
80
80
0000
100100100100
200200200200
300300300300
400400400400
500500500500
600600600600
700700700700
U.S. PopU.S. PopU.S. PopU.S. Pop
TxpTxpTxpTxp
HemoHemoHemoHemo
PDPDPDPD
![Page 3: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/3.jpg)
Benefit From Higher Dose: The Solution?
The London Daily/Nocturnal Hemodialysis StudyThe London Daily/Nocturnal Hemodialysis StudyThe London Daily/Nocturnal Hemodialysis StudyThe London Daily/Nocturnal Hemodialysis Study,
a prospective, comparative, nonrandomized study, directly compared outcomes of quotidian (daily)hemodialysis patients with conventional thrice-weekly hemodialysis patients. Significant clinicalimprovements were seen with quotidian therapy in the areas of nutrition (short-hours daily), bloodpressure (both), volume control (short-hours daily), calcium/phosphorus control (nocturnal), and qualityof life (both). A nonsignificant trend for improvement in anemia management was suggested. Theeconomic analysis showed substantial savings in annualized cost per quality-adjusted life-year inchanging from conventional hemodialysis (carried out in-center, in satellite units, or at home) to home
quotidian hemodialysis.
l l 3
quotidian hemodialysis.
TheTheTheThe substantialsubstantialsubstantialsubstantial clinicalclinicalclinicalclinical benefitsbenefitsbenefitsbenefits ofofofof homehomehomehome quotidianquotidianquotidianquotidianhemodialysis,hemodialysis,hemodialysis,hemodialysis, combinedcombinedcombinedcombined withwithwithwith thethethethe economiceconomiceconomiceconomicadvantageadvantageadvantageadvantage shownshownshownshown bybybyby thisthisthisthis study,study,study,study, clearlyclearlyclearlyclearly justifyjustifyjustifyjustify itsitsitsitsexpansionexpansionexpansionexpansion....
![Page 4: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/4.jpg)
Benefit From Higher Dose: The Solution?
l l 4
![Page 5: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/5.jpg)
Barriers to Higher Dose
Center hemo
Center self hemo
Home hemo
CAPD
CCPD
l l 5
CCPD
Other PD
Uncertain dialysis
Uncertain Transplant
![Page 6: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/6.jpg)
Barriers to Higher Dose
l l 6
![Page 7: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/7.jpg)
Arrythmia Care as a Paradigm for the 21st Century
l l 7
??
![Page 8: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/8.jpg)
Miniaturization?
l l 8
![Page 9: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/9.jpg)
The Kidney’s Natural Hemofilter
l l 9
![Page 10: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/10.jpg)
Uniformity of Pores and Shape of Pores Control Selectivity
l l 10
![Page 11: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/11.jpg)
Silicon Nanopore MembraneSilicon Nanopore Membrane
l l 11
![Page 12: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/12.jpg)
Enhanced Selectivity of Slit Pores
l l 12
![Page 13: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/13.jpg)
Silicon Nanopore Membrane: SelectivitySilicon Nanopore Membrane: Selectivity
l l 13
![Page 14: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/14.jpg)
Large Animal Hemofilter Implantation
l l 14
![Page 15: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/15.jpg)
AcknowledgementsAcknowledgements
•• H. David Humes/Roger Wiggins/Chip BrosiusH. David Humes/Roger Wiggins/Chip Brosius
•• Shuvo Roy & Aaron FleischmanShuvo Roy & Aaron Fleischman
•• Roger MarchantRoger Marchant
•• Andrew L. ZydneyAndrew L. Zydney
l l 15
•• Andrew L. ZydneyAndrew L. Zydney
•• Terry ConliskTerry Conlisk
•• NIH/NIBIB K08/R21/Quantum GrantNIH/NIBIB K08/R21/Quantum Grant
•• Cleveland Clinic FoundationCleveland Clinic Foundation
![Page 16: Silicon Nanotechnology and Hemofiltration Membranes · 2020. 8. 13. · • H. David Humes/Roger Wiggins/Chip Brosius • Shuvo Roy & Aaron Fleischman • Roger Marchant • Andrew](https://reader036.vdocuments.mx/reader036/viewer/2022071504/61242d08328c173c3d5c7cd7/html5/thumbnails/16.jpg)
“One must not stay within the lines”- Eric Carle
l l 16